Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Kyle Piskel currently holds 259,840 shares of Adaptive Biotechnologies Corp (ADPT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kyle Piskel has been a net seller of ADPT stock. They have purchased $0 and sold $3.6M worth of shares.
Kyle Piskel's most recent insider trade was on Mar 11, 2026, when they sold 18,672 shares at $13.17 per share.
Kyle Piskel serves as Executive at Adaptive Biotechnologies Corp (ADPT). They have executed 25 insider transactions totaling $3.6M over their tenure at the company.
Kyle Piskel holds the position of Executive at Adaptive Biotechnologies Corp, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Kyle Piskel has shown a selling trading pattern, with $0 in total purchases and $3.6M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Kyle Piskel was on Nov 28, 2025, when they sold $3.2M worth of ADPT shares. This transaction involved 162,820 shares at $19.50 per share.
Kyle Piskel currently owns 259,840 shares of Adaptive Biotechnologies Corp (ADPT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Kyle Piskel's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Kyle Piskel has 25 Form 4 filings on record as an insider at Adaptive Biotechnologies Corp.
Set alerts for Kyle Piskel and 40,000+ other insiders.